Key Highlights

  • CACI's financial year ended and aggregated market data lists 5 August as the next reporting date.
  • In the third quarter of fiscal 2026, to 31 March, revenue rose 8.5% to US$2,351.0m, 6.8 percentage points of it organic.
  • The mix shift is the argument. Technology now outsells expertise, margin guidance was raised on organic performance, and programmes such as Spectral are moving into production, where defence electronics work usually starts paying properly.
  • Leverage is now the swing factor. The interest burden on more than US$5.1bn of debt already shows in the trimmed adjusted EPS guidance, and deleveraging leans on free cash flow that itself depends on roughly US$90m of tax items.

Why the next week matters more than the last quarter

CACI International Inc (NYSE:CACI). That values the Reston, Virginia group at about US$10.55bn on some 22.1 million shares.

CACI's financial year ended and aggregated market data lists 5 August as the next reporting date. The latest hard numbers cover only the quarter to, so a full year lands at once.

What will be judged is a company mid-transformation: in March it closed a US$2.6bn all-cash acquisition, raised revenue and margin guidance and cut adjusted earnings guidance in the same statement.

What the company does

CACI sells expertise and technology to United States national-security customers. Expertise is people placed on government programmes; technology is product, software-defined signals intelligence, electronic warfare, photonics, space systems and, per its fiscal 2024 annual report, counter-unmanned aircraft system (C-UAS) solutions that "provide electromagnetic spectrum advantage".

The customer base is narrow. In fiscal 2025 the federal government supplied 95.7% of revenue and the Department of Defense alone 75.4%, with 97.0% earned domestically. Staff numbered about 25,000.

Over the nine months, technology revenue of US$3,923.9m overtook expertise revenue of US$2,934.8m. By contract type, cost-plus-fee work supplied US$3,966.0m, fixed-price US$1,959.4m and time-and-materials US$933.3m.

Latest financial and operating performance

In the third quarter of fiscal 2026, to 31 March, revenue rose 8.5% to US$2,351.0m, 6.8 percentage points of it organic. Net income was US$130.4m, up 16.6%, diluted earnings per share US$5.88 and adjusted diluted EPS US$7.27, up 16.7%. EBITDA was US$289.7m at a 12.3% margin after US$17.4m of acquisition expenses, and free cash flow US$221.4m.

Across the nine months, revenue was US$6,858.7m against US$6,323.7m a year earlier, adjusted diluted EPS US$20.92 and free cash flow US$502.6m.

The order book is the metric to follow. Awards totalled US$2.2bn in the quarter, roughly 26% of it new business, and US$8.60bn over nine months, a book-to-bill near 1.25 times nine-month revenue on. Backlog stood at US$33.4bn, up 6.4%, with funded backlog of US$5.0bn, up 19.0%.

Guidance revised calls for revenue of US$9,500m to US$9,600m, adjusted diluted EPS of US$27.70 to US$28.38, an EBITDA margin of 11.8% to 11.9% and free cash flow of at least US$725m, the last leaning on roughly US$90m of one-off and legislative tax benefits.

The catalyst that matters: ARKA, and the price of buying growth

CACI completed the US$2.6bn all-cash purchase of ARKA Group L.P., adding electro-optical and infrared sensing, hyperspectral imaging and agentic artificial intelligence, and expected to add roughly US$150m of revenue by 30 June.

The guidance revision tells the story. Revenue guidance rose US$200m at the midpoint and margin guidance improved, yet adjusted diluted EPS guidance was cut: the deal adds sales and margin but not, yet, earnings per share, because it was funded with debt.

At 31 March long-term debt was US$5,180.6m against cash of US$158.0m. Net debt near US$5.0bn against implied full-year EBITDA of roughly US$1.13bn is leverage in the mid-four-times area, though a full year of ARKA earnings would lower it.

The logic is a shift from labour to product, higher-margin and, once in production, less exposed to the recompete cycle. Spectral, CACI's electronic-warfare programme, passed Milestone C into low-rate initial production, and in May came selection for Phase 3 of the Space Force Enterprise Space Terminal programme.

The bull case

The mix shift is the argument. Technology now outsells expertise, margin guidance was raised on organic performance, and programmes such as Spectral are moving into production, where defence electronics work usually starts paying properly.

Visibility is good. Backlog of US$33.4bn is close to three and a half times annualised revenue, and funded backlog, the portion actually appropriated, grew 19.0%.

Guided free cash flow of at least US$725m is about US$32.80 per share, near 6.9% of the 30 July close, and the midpoint of adjusted EPS guidance puts the shares on roughly 17 times. Dr Dave Young, previously of Lockheed Martin's national security space business, became chief operating officer.

The bear case and the risks

Leverage is now the swing factor. The interest burden on more than US$5.1bn of debt already shows in the trimmed adjusted EPS guidance, and deleveraging leans on free cash flow that itself depends on roughly US$90m of tax items.

Customer concentration and budget mechanics. With 95.7% of fiscal 2025 revenue federal, appropriations dictate outcomes. CACI's own risk factors note that a continuing resolution "traditionally does not authorize new spending initiatives", that agencies "generally have the right not to exercise" option periods, and that bid protests are increasing.

Backlog quality and recompete exposure. Only US$5.0bn of the US$33.4bn backlog is funded, about 15%. Cost-plus work, thin by construction, was 57.8% of nine-month revenue; the 28.6% fixed-price book carries the opposite risk, since overruns land on CACI.

Integration amid leadership change. DeEtte Gray, president of US operations, left the role for an advisory position until 31 December, days after the new chief operating officer arrived. Absorbing a US$2.6bn acquisition through a handover is not trivial.

The drone-defence angle is unquantified. C-UAS and spectrum work are named capabilities, but CACI discloses no counter-drone revenue line, so the thesis cannot be sized from the filings.

What investors should watch next

The 5 August print. Test the fiscal 2026 outcome against April's guidance on revenue, adjusted EPS, margin and free cash flow.

Initial fiscal 2027 guidance, and whether the multi-year targets referenced in April are reaffirmed. That, rather than the year just closed, will set the shares.

Full-year awards and book-to-bill against fiscal 2025's US$9.6bn and 1.1 times, and backlog against the US$33.4bn and US$5.0bn marks.

ARKA's first undistorted quarter, and year-end debt and cash as a read on how quickly leverage is falling.

Appropriations. The US federal year begins on 1 October; whether agencies start it funded or under a continuing resolution bears on new-start awards and backlog conversion.

Investor takeaway

CACI arrives with real operating momentum: technology revenue has overtaken expertise, funded backlog is up 19.0%, nine-month awards of US$8.60bn exceed nine-month revenue, and margin guidance rose on organic performance.

The counterweight is the balance sheet. Paying US$2.6bn in cash left more than US$5.1bn of debt against US$158.0m of cash, and the immediate effect was lower adjusted earnings guidance even as revenue guidance rose; the outlook also leans on roughly US$90m of tax one-offs.

At about 17 times the midpoint of guided adjusted earnings, the shares are not priced for disappointment. Fiscal 2026 results and first fiscal 2027 guidance, due, should settle which reading the market accepts. Nothing here is a recommendation to buy or sell.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Share prices can rise or fall, and past performance does not guarantee future results. Investors should conduct independent research and consult a licensed financial adviser before making investment decisions.